Dendritic  	Dendritic  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
pulsed  	pulsed  	 VBN	O
with  	with  	 IN	O
tumor  	tumor  	 NN	B-NP
cells  	cells  	 NNS	I-NP
killed  	killed  	 VBN	O
by  	by  	 IN	O
high  	high  	 JJ	O
hydrostatic  	hydrostatic  	 JJ	B-NP
pressure  	pressure  	 NN	I-NP
induce  	induce  	 VB	O
strong  	strong  	 JJ	O
immune  	immune  	 JJ	O
responses  	responses  	 NNS	O
and  	and  	 CC	O
display  	display  	 VB	O
therapeutic  	therapeutic  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
both  	both  	 CC	O
in  	in  	 IN	O
murine  	murine  	 JJ	B-NP
TC-1  	TC-1  	 NN	I-NP
and  	and  	 CC	O
TRAMP-C2  	TRAMP-C2  	 CD	B-NP
tumors  	tumors  	 NNS	I-NP
when  	when  	 WRB	O
combined  	combined  	 VBN	O
with  	with  	 IN	O
docetaxel  	docetaxel  	 JJ	B-NP
chemotherapy  	chemotherapy  	 JJ	I-NP
High  	High  	 JJ	I-NP
hydrostatic  	hydrostatic  	 JJ	I-NP
pressure  	pressure  	 NN	I-NP
( 	( 	 -LRB-	O
HHP 	HHP 	 NNP	B-NP
)  	)  	 -RRB-	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
shown  	shown  	 VBN	O
to  	to  	 TO	O
induce  	induce  	 VB	O
immunogenic  	immunogenic  	 JJ	B-NP
cell  	cell  	 NN	I-NP
death  	death  	 NN	I-NP
of  	of  	 IN	I-NP
cancer  	cancer  	 NN	I-NP
cells 	cells 	 NNS	I-NP
,  	,  	 ,	O
facilitating  	facilitating  	 VBG	O
their  	their  	 PRP$	O
uptake  	uptake  	 NN	O
by  	by  	 IN	O
dendritic  	dendritic  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
( 	( 	 -LRB-	O
DC 	DC 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
subsequent  	subsequent  	 JJ	O
presentation  	presentation  	 NN	B-NP
of  	of  	 IN	I-NP
tumor  	tumor  	 NN	I-NP
antigens 	antigens 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
present  	present  	 JJ	O
study 	study 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
demonstrated  	demonstrated  	 VBD	O
immunogenicity  	immunogenicity  	 VBN	O
of  	of  	 IN	O
the  	the  	 DT	O
HHP-treated  	HHP-treated  	 JJ	B-NP
tumor  	tumor  	 NN	I-NP
cells  	cells  	 NNS	I-NP
in  	in  	 IN	O
mice 	mice 	 NNS	O
.  	.  	 .	O
HHP  	HHP  	 NNP	B-NP
was  	was  	 VBD	O
able  	able  	 JJ	O
to  	to  	 TO	O
induce  	induce  	 VB	O
immunogenic  	immunogenic  	 JJ	B-NP
cell  	cell  	 NN	I-NP
death  	death  	 NN	I-NP
of  	of  	 IN	O
both  	both  	 DT	O
TC-1  	TC-1  	 NNP	B-NP
and  	and  	 CC	O
TRAMP-C2  	TRAMP-C2  	 CD	B-NP
tumor  	tumor  	 NN	I-NP
cells 	cells 	 NNS	I-NP
,  	,  	 ,	O
representing  	representing  	 VBG	O
murine  	murine  	 JJ	B-NP
models  	models  	 NNS	I-NP
for  	for  	 IN	O
human  	human  	 JJ	O
papilloma  	papilloma  	 JJ	B-NP
virus-associated  	virus-associated  	 JJ	I-NP
tumors  	tumors  	 NNS	I-NP
and  	and  	 CC	O
prostate  	prostate  	 JJ	B-NP
cancer 	cancer 	 NN	I-NP
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
HHP-treated  	HHP-treated  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
induced  	induced  	 VBP	O
stronger  	stronger  	 JJR	O
immune  	immune  	 JJ	O
responses  	responses  	 NNS	O
in  	in  	 IN	O
mice  	mice  	 JJ	O
immunized  	immunized  	 NN	O
with  	with  	 IN	O
these  	these  	 DT	O
tumor  	tumor  	 NN	B-NP
cells 	cells 	 NNS	I-NP
,  	,  	 ,	O
documented  	documented  	 VBN	O
by  	by  	 IN	O
higher  	higher  	 JJR	O
spleen  	spleen  	 JJ	B-NP
cell  	cell  	 NN	I-NP
cytotoxicity  	cytotoxicity  	 NNS	I-NP
and  	and  	 CC	O
increased  	increased  	 VBD	O
IFNγ  	IFNγ  	 JJ	B-NP
production  	production  	 NN	I-NP
as  	as  	 IN	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
irradiated  	irradiated  	 VB	B-NP
tumor  	tumor  	 NN	I-NP
cells 	cells 	 NNS	I-NP
,  	,  	 ,	O
accompanied  	accompanied  	 VBN	O
by  	by  	 IN	O
suppression  	suppression  	 NN	O
of  	of  	 IN	O
tumor  	tumor  	 NN	B-NP
growth  	growth  	 NN	I-NP
in vivo  	in vivo  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
case  	case  	 NN	O
of  	of  	 IN	O
TC-1  	TC-1  	 CD	B-NP
tumors 	tumors 	 NNS	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
not  	not  	 RB	O
TRAMP-C2  	TRAMP-C2  	 CD	B-NP
tumors 	tumors 	 NNS	I-NP
.  	.  	 .	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
HHP-treated  	HHP-treated  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
were  	were  	 VBD	O
used  	used  	 VBN	O
for  	for  	 IN	O
DC-based  	DC-based  	 JJ	B-NP
vaccine  	vaccine  	 NN	I-NP
antigen  	antigen  	 NN	I-NP
pulsing 	pulsing 	 NN	I-NP
.  	.  	 .	O
DC  	DC  	 NNP	B-NP
co-cultured  	co-cultured  	 NNP	O
with  	with  	 IN	O
HHP-treated  	HHP-treated  	 JJ	B-NP
tumor  	tumor  	 NN	I-NP
cells  	cells  	 NNS	I-NP
and  	and  	 CC	O
matured  	matured  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
TLR  	TLR  	 NNP	B-NP
9  	9  	 CD	O
agonist  	agonist  	 NNS	B-NP
exhibited  	exhibited  	 VBP	O
higher  	higher  	 JJR	O
cell  	cell  	 NN	O
surface  	surface  	 NN	O
expression  	expression  	 NN	O
of  	of  	 IN	O
maturation  	maturation  	 JJ	B-NP
markers  	markers  	 NN	I-NP
and  	and  	 CC	O
production  	production  	 NN	O
of  	of  	 IN	O
IL-12  	IL-12  	 NNP	B-NP
and  	and  	 CC	O
other  	other  	 JJ	O
cytokines 	cytokines 	 NN	B-NP
,  	,  	 ,	O
as  	as  	 RB	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
DC  	DC  	 NNP	B-NP
pulsed  	pulsed  	 NN	I-NP
with  	with  	 IN	O
irradiated  	irradiated  	 JJ	O
tumor  	tumor  	 NN	B-NP
cells 	cells 	 NNS	I-NP
.  	.  	 .	O
Immunization  	Immunization  	 NNP	B-NP
with  	with  	 IN	O
DC  	DC  	 NNP	B-NP
cell-based  	cell-based  	 JJ	O
vaccines  	vaccines  	 JJ	O
pulsed  	pulsed  	 NN	O
with  	with  	 IN	O
HHP-treated  	HHP-treated  	 JJ	B-NP
tumor  	tumor  	 NN	I-NP
cells  	cells  	 NNS	I-NP
induced  	induced  	 VBP	O
high  	high  	 JJ	O
immune  	immune  	 JJ	O
responses 	responses 	 NNS	O
,  	,  	 ,	O
detected  	detected  	 VBN	O
by  	by  	 IN	O
increased  	increased  	 JJ	O
spleen  	spleen  	 JJ	B-NP
cell  	cell  	 NN	I-NP
cytotoxicity  	cytotoxicity  	 NNS	I-NP
and  	and  	 CC	O
elevated  	elevated  	 VBD	O
IFNγ  	IFNγ  	 JJ	B-NP
production 	production 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
DC-based  	DC-based  	 JJ	B-NP
vaccine  	vaccine  	 NN	I-NP
pulsed  	pulsed  	 NN	I-NP
with  	with  	 IN	O
HHP-treated  	HHP-treated  	 JJ	B-NP
tumor  	tumor  	 NN	I-NP
cells  	cells  	 NNS	I-NP
combined  	combined  	 VBN	O
with  	with  	 IN	O
docetaxel  	docetaxel  	 JJ	B-NP
chemotherapy  	chemotherapy  	 NNS	I-NP
significantly  	significantly  	 RB	O
inhibited  	inhibited  	 JJ	O
growth  	growth  	 NN	B-NP
of  	of  	 IN	O
both  	both  	 DT	O
TC-1  	TC-1  	 NNP	B-NP
and  	and  	 CC	O
TRAMP-C2  	TRAMP-C2  	 CD	B-NP
tumors 	tumors 	 NNS	I-NP
.  	.  	 .	O
Our  	Our  	 PRP$	O
results  	results  	 NNS	O
indicate  	indicate  	 VBP	O
that  	that  	 IN	O
DC-based  	DC-based  	 JJ	B-NP
vaccines  	vaccines  	 JJ	I-NP
pulsed  	pulsed  	 NN	O
with  	with  	 IN	O
HHP-inactivated  	HHP-inactivated  	 JJ	B-NP
tumor  	tumor  	 NN	I-NP
cells  	cells  	 NNS	I-NP
can  	can  	 MD	O
be  	be  	 VB	O
a  	a  	 DT	O
suitable  	suitable  	 JJ	O
tool  	tool  	 NN	O
for  	for  	 IN	O
chemoimmunotherapy 	chemoimmunotherapy 	 NN	B-NP
,  	,  	 ,	O
particularly  	particularly  	 RB	O
with  	with  	 IN	O
regard  	regard  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
findings  	findings  	 NNS	O
that  	that  	 WDT	O
poorly  	poorly  	 RB	O
immunogenic  	immunogenic  	 CD	B-NP
TRAMP-C2  	TRAMP-C2  	 CD	I-NP
tumors  	tumors  	 NNS	I-NP
were  	were  	 VBD	O
susceptible  	susceptible  	 JJ	O
to  	to  	 TO	O
this  	this  	 DT	O
treatment  	treatment  	 NN	B-NP
modality 	modality 	 NN	I-NP
.  	.  	 .	O
